Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator that may improve peripheral circulation. Its mechanism of action is not fully understood but is thought to involve direct relaxation of vascular smooth muscle.
## Primary Indications
* Treatment of peripheral vascular diseases such as intermittent claudication and Raynaud's disease.
* Potentially used to prevent premature labor by relaxing uterine smooth muscle (off-label, efficacy and safety are uncertain).
## Adult Dosing
* **Peripheral Vascular Disease:** Typically 10 mg to 20 mg orally three to four times daily.
* **Premature Labor (Off-label):** Dosing varies widely and is not well-established. Some sources suggest initial doses of 10 mg to 20 mg orally every 3-4 hours, with maintenance doses of 10 mg orally every 4-6 hours. **Efficacy and safety for this indication are not definitively proven.**
## Pediatric Dosing
There is no established pediatric dosing for isoxsuprine hydrochloride.
## Dose Adjustments
No specific dose adjustments are recommended for renal or hepatic impairment due to limited data. Use with caution.
## Contraindications
* Known hypersensitivity to isoxsuprine hydrochloride.
* Should not be administered immediately postpartum or before childbirth due to potential risk to the mother and infant.
## Adverse Effects
* **Common:** Hypotension, flushing, dizziness, nausea, vomiting, abdominal distress, rash, weakness, nervousness, palpitations.
* **Serious:** Severe hypotension, especially with rapid IV administration (though IV route is not recommended for routine use and often unavailable).
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications.
* **Other Vasodilators:** Additive hypotensive effects may occur.
## Monitoring
* Blood pressure and heart rate.
* Signs and symptoms of peripheral vascular disease improvement.
* For off-label use in premature labor, monitor uterine contractions and fetal well-being.
## Clinical Pearls
* Isoxsuprine's effectiveness in peripheral vascular disease is controversial, and it is not a first-line agent.
* Use with caution in patients with hypotension or cardiovascular disease.
* Oral administration is preferred. Intravenous administration carries a higher risk of severe hypotension and is generally avoided.
* Efficacy and safety for tocolysis (prevention of premature labor) are not well-established and it is considered an off-label use with uncertain benefit.
**Please verify current prescribing information and local protocols for definitive guidance, as drug information can change and may vary by jurisdiction.**
